Stay updated on Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial

Sign up to get notified when there's something new on the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T14:21:20.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added to the page. The lapse-in-funding notice and the Revision: v3.4.1 entry have been removed.
    Difference
    0.3%
    Check dated 2026-02-11T01:49:44.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A government funding notice was added noting potential processing delays and that the NIH Clinical Center is open, and the page was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-03T22:57:48.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Added a 'Show glossary' control and updated QC-related labels to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.1%
    Check dated 2026-01-27T16:59:19.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.3.4 added and Revision: v3.3.3 removed on the page. This appears to be a minor documentation update without affecting study details or results.
    Difference
    0.0%
    Check dated 2026-01-20T14:11:53.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A full list of trial locations across US states and Canadian provinces was added and the revision updated to v3.3.3, while prior location blocks and the HHS Vulnerability Disclosure entry were removed.
    Difference
    2%
    Check dated 2025-12-23T00:30:31.000Z thumbnail image

Stay in the know with updates to Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page.